Status:
COMPLETED
Effect of Angeliq on Blood Pressure (BP) in Postmenopausal Hypertensive Women
Lead Sponsor:
Bayer
Conditions:
Hypertension
Postmenopause
Eligibility:
FEMALE
45-75 years
Phase:
PHASE3
Brief Summary
The objective of the study is to evaluate the effects of Angeliq on BP over a period of 8 weeks in postmenopausal women who may benefit from hormone replacement therapy (HRT) for the relief of vasomot...
Detailed Description
This study has previously been posted by Berlex, Inc. Berlex, Inc. has been renamed to Bayer HealthCare Pharmaceuticals, Inc.Bayer HealthCare Pharmaceuticals, Inc.is the sponsor of the trial.
Eligibility Criteria
Inclusion
- Inclusion Criteria:- Have hypertension- Are currently taking antihypertensive medications- Have had natural menopause at least 1 year prior to screening- Must require hormone therapy in the opinion of the investigator
Exclusion
Key Trial Info
Start Date :
April 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2005
Estimated Enrollment :
750 Patients enrolled
Trial Details
Trial ID
NCT00102141
Start Date
April 1 2004
End Date
July 1 2005
Last Update
December 15 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.